TITLE

Factors Influencing Clinical Decisions to Initiate Thyroxine Therapy for Patients With Mildly Increased Serum Thyrotropin (5.1-10.0 mIU/L)

AUTHOR(S)
Fatourechi, Vahab; Lankarani, Mahnaz; Schryver, Patricia G.; Vanness, David J.; Long, Kirsten Hall; Klee, George G.
PUB. DATE
May 2003
SOURCE
Mayo Clinic Proceedings;May2003, Vol. 78 Issue 5, p554
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Determines factors that influence clinicians' decisions to treat subclinical hypothyroidism. Most common abnormality of thyrotropin; Reasons for initiating thyroxine therapy for antibody-positive patients; Issue of physician reluctance to use thyroxine therapy for older patients.
ACCESSION #
9749428

 

Related Articles

  • Growth, development, and reassurement of hypothyroid infants diagnosed by screening. Hulse, J.A.; Grant, D.B.; Jackson, Doreen; Clayton, Barbara E. // British Medical Journal (Clinical Research Edition);5/15/1982, Vol. 284 Issue 6327, p1435 

    Reassesses the hypothyroid infants after the thyroid stimulating hormone screening. Analysis of the mental development scores; Association between thyroid stimulating hormone concentrations and concentrations of serum thyroxine (T4); Importance of regular monitoring for the serum T4...

  • Health Status, Psychological Symptoms, Mood, and Cognition in L-Thyroxine-Treated Hypothyroid Subjects. Mary H. Samuels; Kathryn G. Schuff; Nichole E. Carlson; Phyllis Carello; Jeri S. Janowsky // Thyroid;Mar2007, Vol. 17 Issue 3, p249 

    Objective: Many hypothyroid subjects receiving L-thyroxine (L-T4) complain of psychological symptoms or cognitive dysfunction. However, there is limited validated information on these self-reports. Design: Cross-sectional comparison of 20 euthyroid and 34 treated hypothyroid subjects, aged...

  • Neonatal screening for congenital hypothyroidism by measurement of plasma thyroxine and thyroid stimulating hormone concentrations. Griffiths, K.D.; Virdi, Narinder K.; Rayner, P.H.W.; Green, Anne // British Medical Journal (Clinical Research Edition);7/13/1985, Vol. 291 Issue 6488, p117 

    Assesses plasma thyroxine and thyroid stimulating hormone measurement for congenital hypothyroidism screening in Birmingham, England. Detection of an abnormality in thyroxine binding globulin production; Incidence of congenital hypothyroidism in Asian population; Disadvantages of the test.

  • Subclinical hypothyroidism in childhood. MJ O'Grady // Archives of Disease in Childhood;Mar2011, Vol. 96 Issue 3, p280 

    Subclinical hypothyroidism (SH) is defined as an elevated thyroid stimulating hormone (TSH) in association with a normal total or free thyroxine (T4) or triiodothyronine (T3). It is frequently encountered in both neonatology and general paediatric practice; however, its clinical significance is...

  • Primary hypothyroidism presenting as amenorrhoea and galactorrhoea with hyperprolactinaemia and pituitary enlargement. Heyburn, P.J.; Gibby, O.M.; Hourihan, M.; Hall, R.; Scanlon, M.F. // British Medical Journal (Clinical Research Edition);6/21/1986, Vol. 292 Issue 6536, p1660 

    Investigates the primary hypothyroidism in patients with the amenorrhea and galactorrhea syndrome. Cause of hyperprolactinemia; Association of adenomas secreting thyroid stimulating hormone with primary thyroid failure; Use of thyroxine in the resolution of symptoms.

  • Soy formula complicates management of congenital hypothyroidism. Conrad S C; Chiu H; Silverman B L // Archives of Disease in Childhood;Jan2004, Vol. 89 Issue 1, p37 

    AIMS: To test the hypothesis that feeding soy formula to infants with congenital hypothyroidism (CH) leads to prolonged increase of thyroid stimulating hormone (TSH). METHODS: The study was a review of 78 patients seen during their first year of life between 1990 and 1998. Data regarding...

  • Scintigraphic evaluation of primary congenital hypothyroidism: results of the Greek screening program. Panoutsopoulos, G.; Mengreli, C.; Ilias, I.; Batsakis, C.; Christakopoulou, I. // European Journal of Nuclear Medicine;2001, Vol. 28 Issue 4, p529 

    Abstract. The Greek screening program for primary congenital hypothyroidism was initiated in 1979. By early 2000, thyrotropin measurements had been performed in 1,976,719 newborns, using dried blood spots obtained by heel prick. Among these children, 584 were diagnosed with congenital...

  • Outcome of lower L-thyroxine dose for treatment of congenital hypothyroidism. Campos, Susana P.; Sandberg, David E. // Clinical Pediatrics;Oct1995, Vol. 34 Issue 10, p514 

    Evaluates the intellectual, behavioral, and growth outcomes of 23 congenitally hypothyroid newborns diagnosed by the New York State Neonatal Thyroid Screening Program and initially treated with 25 micrograms of L-thyroxine. Increased serum thyroxine (T4) values; Elevation of thyroid-stimulating...

  • Thyroxine dose for congenital hypothyroidism. Ehrlich, Robert M. // Clinical Pediatrics;Oct1995, Vol. 34 Issue 10, p521 

    Editorial. Discusses the detection and treatment of congenital hypothyroidism (CH). Newborn screening; Treatment with levothyroxine; Use of the serum thyroxine (T4) or thyroid-stimulating hormone (TSH) levels by screening programs; Recommendations of the American Academy of Pediatrics;...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics